Syncope recurrence and mortality: a systematic review.

AIMS Data on adverse events and death rates following syncope are heterogeneous among studies, and knowledge of syncope prognosis could help to better define the correct management of patients. METHODS AND RESULTS We performed a systematic review of literature by searching for prospective observational studies enrolling consecutive patients presenting to the Emergency Department because of syncope. The outcomes considered were syncope recurrence and short- and long-term mortality. Morbidity and a composite of morbidity and mortality were also assessed. Pooled event rates and 95% confidence intervals (CI) were calculated for each outcome using the random effects model. Twenty-five studies (11 158 patients) were included. The incidence of syncope relapse linearly increased from 0.3% at 30 days to 22% at 2 years follow-up. One-year mortality rate varied between 5.7 and 15.5%; the pooled estimate was 8.4% (95% CI: 6.7-10.2%). The incidence of adverse events (morbidity) varied between 6.1 and 25.2% at 10 days and 2 years, respectively. The short-term (10 days) pooled incidence of the composite of morbidity and mortality was 9.1% (95% CI: 6.6-12.5%). We found a high statistical heterogeneity between studies. CONCLUSION This meta-analysis of prospective observational studies shows that the chance of being asymptomatic linearly progressively decreased over time after the first syncope. Short-term (10-30 days) mortality after syncope was <2% and that the overall 10-day rate of the composite endpoint of death and major events was ∼9%. The knowledge of syncope prognosis could help clinicians to understand syncope patients' prognosis and researchers to design future studies.

[1]  R. Furlan,et al.  Syncope risk stratification tools vs clinical judgment: an individual patient data meta-analysis. , 2014, The American journal of medicine.

[2]  R. Furlan,et al.  Driving and Working with Syncope , 2014, Autonomic Neuroscience.

[3]  L. Køber,et al.  Incidence and influence of hospitalization for recurrent syncope and its effect on short- and long-term all-cause and cardiovascular mortality. , 2014, The American journal of cardiology.

[4]  L. Køber,et al.  Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age. , 2013, The American journal of cardiology.

[5]  R. Furlan,et al.  Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: an international meta-analysis. , 2013, International journal of cardiology.

[6]  G. Costantino,et al.  Does the absence of comorbidities really identify low-risk syncope patients? , 2013, Journal of the American College of Cardiology.

[7]  R. Furlan,et al.  Do work accidents play any role in the increased risk of death observed in 25- to 44-year-old patients after syncope? , 2013, Journal of the American College of Cardiology.

[8]  L. Køber,et al.  Prognosis among healthy individuals discharged with a primary diagnosis of syncope. , 2013, Journal of the American College of Cardiology.

[9]  R. Furlan,et al.  [Syncope and occupational risk survey: the role of continuing education and multidisciplinary approach]. , 2011, Giornale italiano di medicina del lavoro ed ergonomia.

[10]  R. Sheldon,et al.  Recent History of Vasovagal Syncope in a Young, Referral‐Based Population Is a Stronger Predictor of Recurrent Syncope Than Lifetime Syncope Burden , 2010, Journal of cardiovascular electrophysiology.

[11]  J. Iwanicki,et al.  The ROSE (Risk Stratification of Syncope in the Emergency Department) Study , 2010 .

[12]  R. Furlan,et al.  Short- and long-term prognosis of syncope, risk factors, and role of hospital admission: results from the STePS (Short-Term Prognosis of Syncope) study. , 2008, Journal of the American College of Cardiology.

[13]  Jill Hayden,et al.  Evaluation of the Quality of Prognosis Studies in Systematic Reviews , 2006, Annals of Internal Medicine.

[14]  W. Shen,et al.  Epidemiology of reflex syncope , 2004, Clinical Autonomic Research.

[15]  J. Townend,et al.  Effects of nitroglycerin treatment on cardiac autonomic control in heart failure , 2004, Clinical autonomic research : official journal of the Clinical Autonomic Research Society.

[16]  George A Wells,et al.  Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. , 2004, Annals of emergency medicine.

[17]  D. Levy,et al.  Incidence and prognosis of syncope. , 2002, The New England journal of medicine.

[18]  MicheleBrignole,et al.  Mechanism of Syncope in Patients With Isolated Syncope and in Patients With Tilt-Positive Syncope , 2001 .

[19]  G. Minardi,et al.  [The management of syncope in the hospital: the OESIL Study (Osservatorio Epidemiologico della Sincope nel Lazio)]. , 1999, Giornale italiano di cardiologia.

[20]  B. Hanusa,et al.  Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. , 1996, The American journal of medicine.

[21]  W. Kapoor,et al.  Evaluation and Outcome of Patients with Syncope , 1990, Medicine.